Sprix Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Sprix General Information
Description
Producer of pain reliever spray used in hospitals. The company's spray is a non-steroidal anti-inflammatory drug used as a short-term treatment for moderate to moderately severe pain that requires anaglesia at the opioid level.
Contact Information
Website
www.sprix.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- Regency Therapeutics, 1 Luitpold Drive
- P.O. Box 9001
- Shirley, NY 11967
- United States
Sprix Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sprix Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|